Login

NON-SUBSCRIBER OPTIONS
FREE TRIAL   |   NEWSSTAND

Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

Key GOP House members are signaling cautious support for the Senate Finance Committee’s bipartisan drug pricing plan after a meeting between HHS Secretary Alex Azar, House Republicans and Senate Finance Chair Chuck Grassley (R-IA) on Thursday (Sept. 19).


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.